Table 1—

Clinical parameters of study population (N = 735) recorded in 1993 and values at the end of the study of the variables monitored during follow-up

Variables19931998
Family history for CHD (n)198
Fasting C-peptide (nmol/l)0.90 ± 0.40
Postprandial C-peptide (nmol/l)2.10 ± 0.98
GHb (% of Hb)7.3 ± 1.57.7 ± 1.6
BMI (kg/m2)27.4 ± 3.927.4 ± 4.0
Total cholesterol (mmol/l)5.56 ± 0.995.58 ± 1.0
HDL cholesterol (mmol/l)1.20 ± 0.31.23 ± 0.3
Triglycerides (mmol/l)2.22 ± 1.262.11 ± 1.26
Systolic blood pressure (mmHg)142.4 ± 18.7141.6 ± 17.7
Diastolic blood pressure (mmHg)84.3 ± 8.881.9 ± 7.9
Smokers198 (26.9)126 (17.1)
Autonomic neuropathy162 (22.0)
Retinopathy39 (5.3)39 (5.3)
Microalbuminuria (>20 and <200 μg/min)162 (22.0)166 (22.6)
Proteinuria (≥200 μg/min)10 (1.4)10 (1.4)
  • Data are n (%) or means ± SD.